Treatment challenges in and outside a specialist network setting: Pancreatic neuroendocrine tumours
Panagis M. Lykoudis(National and Kapodistrian University of Athens), Sandra Mallone(Istituto Superiore di Sanità), Ladislav Dušek(Institute of Health Information and Statistics), Nadya Dimitrova(Istituto Superiore di Sanità), Margit Mägi(Universidad de Granada), Guido Mazzoleni, Alice Nennecke, Jón G. Jónasson(Reykjavík University), Roberta De Angelis(Istituto Superiore di Sanità), Mario Šekerija(London Cancer), Martyn Caplin(The Royal Free Hospital), Marc Maynadié(Universidad de Granada), Giuseppe Fusai(The Royal Free Hospital), Pascale Grosclaude(Seoul National University Children's Hospital), Francesca Muffatti(Vita-Salute San Raffaele University), Florence Molinié, Diego Serraino(Centro di Riferimento Oncologico), Massimo Falconi(Vita-Salute San Raffaele University), Anne‐Sophie Woronoff, Alain Monnereau, Stefano Partelli(Vita-Salute San Raffaele University), Maarit K. Leinonen(University of Helsinki), Véronique Bouvier(Inserm), Anne‐Marie Bouvier(Inserm), Nea Malila(Istituto Superiore di Sanità), Anne‐Valérie Guizard, Simona Bara(Centre Hospitalier Public du Cotentin), Marc Colonna, Bénédicte Lapôtre-Ledoux(Chirurgie et extrémité céphalique, caractérisation morphologique et fonctionnelle), Bernd Holleczek, Monika Hackl(Universidad de Granada), Gabriele Schubert-Fritschle, Jan Heidrich(Universidad de Granada), Roland Stabenow(Fondazione IRCCS Istituto Nazionale dei Tumori), P. Arveux(Istituto Superiore di Sanità), Adriano Giacomin, Antonella Sutera Sardo, Jutta Engel, Brigitte Tretarre, Sabine Luttmann(Fondazione IRCCS Istituto Nazionale dei Tumori), Michel Velten(Pancreatic Cancer Action Network), Kris Henau, E. Van Eycken(Istituto Superiore di Sanità), Alessandro Barchielli(Centro di Riferimento Oncologico), M. Robaszkiewicz(University of Milan), Claire Schvartz(Fondazione IRCCS Istituto Nazionale dei Tumori), Xavier Troussard, Harry Comber(Universidad de Granada), Kerri M. Clough‐Gorr(Boston University), Isabelle Baldi(Pancreatic Cancer Action Network)
Cited by 8
Related Papers
Phase 3 Trial of <sup>177</sup> Lu-Dotatate for Midgut Neuroendocrine Tumors
|New England Journal of Medicine|2017|3.2k
Detection and localization of surgically resectable cancers with a multi-analyte blood test
|Science|2018|2.8k
Gastroenteropancreatic neuroendocrine tumours
|The Lancet Oncology|2008|1.8k